Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure

Background: Anti-Müllerian hormone (AMH) is a member of the transforming growth factor β (TGF-β) family of growth and differentiation factors. AMH is produced by granulosa cells of preantral and small antral follicles.Aim of the study: The aim of the study was to assess the AMH plasma levels of heal...

Full description

Bibliographic Details
Main Authors: Piotr Skałba, Anna Cygal
Format: Article
Language:English
Published: Termedia Publishing House 2011-06-01
Series:Menopause Review
Subjects:
Online Access:http://www.termedia.pl/Stezenie-hormonu-antymullerowskiego-w-surowicy-u-kobiet-z-zespolem-policystycznych-jajnikow-r-ni-w-zespole-przedwczesnego-wygasania-czynnosci-jajnikow,4,16954,1,0.html
_version_ 1818970596308942848
author Piotr Skałba
Anna Cygal
author_facet Piotr Skałba
Anna Cygal
author_sort Piotr Skałba
collection DOAJ
description Background: Anti-Müllerian hormone (AMH) is a member of the transforming growth factor β (TGF-β) family of growth and differentiation factors. AMH is produced by granulosa cells of preantral and small antral follicles.Aim of the study: The aim of the study was to assess the AMH plasma levels of healthy women in reproductive age and in women with polycystic ovary syndrome (PCOS) and premature ovarian failure (POF).Material and methods: The study included 187 women.Results: AMH concentration in serum of patients with PCOS (73.68 ±25.58 pmol/l) was significantly higher than in healthy women (16.97 ±5.80 pmol/l) (p < 0.05). In patients with POF AMH concentrations in blood serum were very low or undetectable, and averaged 0.65 ±1.81 pmol/l. Average concentrations of AMH in the blood serum of the healthy group of patients differed significantly (p < 0.001) between the age-dependent subgroups. AMH concentration in serum of healthy women decreased with age. The average concentration of AMH in the blood serum in PCOS decreased after 30 years of age. There were no statistically significant differences between age subgroups.In the premature ovarian failure patients with secondary amenorrhea persisting for at least three years AMH plasma levels were extremely low (0.16 ±0.10 pmol/l) and showed a significant difference compared to patients whose menses returned.Conclusions:1. In PCOS women the determination of AMH plasma levels can be used to assess severity of the syndrome.2. The determination of AMH in blood serum can be used as a marker of diminished ovarian reserve in premature ovarian failure women.
first_indexed 2024-12-20T14:38:59Z
format Article
id doaj.art-571430cc5d5749ed9ec7f6e0b005c314
institution Directory Open Access Journal
issn 1643-8876
language English
last_indexed 2024-12-20T14:38:59Z
publishDate 2011-06-01
publisher Termedia Publishing House
record_format Article
series Menopause Review
spelling doaj.art-571430cc5d5749ed9ec7f6e0b005c3142022-12-21T19:37:22ZengTermedia Publishing HouseMenopause Review1643-88762011-06-01153232236Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failurePiotr SkałbaAnna CygalBackground: Anti-Müllerian hormone (AMH) is a member of the transforming growth factor β (TGF-β) family of growth and differentiation factors. AMH is produced by granulosa cells of preantral and small antral follicles.Aim of the study: The aim of the study was to assess the AMH plasma levels of healthy women in reproductive age and in women with polycystic ovary syndrome (PCOS) and premature ovarian failure (POF).Material and methods: The study included 187 women.Results: AMH concentration in serum of patients with PCOS (73.68 ±25.58 pmol/l) was significantly higher than in healthy women (16.97 ±5.80 pmol/l) (p < 0.05). In patients with POF AMH concentrations in blood serum were very low or undetectable, and averaged 0.65 ±1.81 pmol/l. Average concentrations of AMH in the blood serum of the healthy group of patients differed significantly (p < 0.001) between the age-dependent subgroups. AMH concentration in serum of healthy women decreased with age. The average concentration of AMH in the blood serum in PCOS decreased after 30 years of age. There were no statistically significant differences between age subgroups.In the premature ovarian failure patients with secondary amenorrhea persisting for at least three years AMH plasma levels were extremely low (0.16 ±0.10 pmol/l) and showed a significant difference compared to patients whose menses returned.Conclusions:1. In PCOS women the determination of AMH plasma levels can be used to assess severity of the syndrome.2. The determination of AMH in blood serum can be used as a marker of diminished ovarian reserve in premature ovarian failure women.http://www.termedia.pl/Stezenie-hormonu-antymullerowskiego-w-surowicy-u-kobiet-z-zespolem-policystycznych-jajnikow-r-ni-w-zespole-przedwczesnego-wygasania-czynnosci-jajnikow,4,16954,1,0.htmlanti-Müllerian hormonepolycystic ovary syndromepremature ovarian failure
spellingShingle Piotr Skałba
Anna Cygal
Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
Menopause Review
anti-Müllerian hormone
polycystic ovary syndrome
premature ovarian failure
title Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
title_full Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
title_fullStr Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
title_full_unstemmed Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
title_short Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
title_sort anti mullerian hormone plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
topic anti-Müllerian hormone
polycystic ovary syndrome
premature ovarian failure
url http://www.termedia.pl/Stezenie-hormonu-antymullerowskiego-w-surowicy-u-kobiet-z-zespolem-policystycznych-jajnikow-r-ni-w-zespole-przedwczesnego-wygasania-czynnosci-jajnikow,4,16954,1,0.html
work_keys_str_mv AT piotrskałba antimullerianhormoneplasmalevelsinwomenwithpolycysticovarysyndromeandwithprematureovarianfailure
AT annacygal antimullerianhormoneplasmalevelsinwomenwithpolycysticovarysyndromeandwithprematureovarianfailure